---
figid: PMC9251145__ECAM2022-8400496.008
pmcid: PMC9251145
image_filename: ECAM2022-8400496.008.jpg
figure_link: /pmc/articles/PMC9251145/figure/fig8/
number: Figure 8
figure_title: ''
caption: 'Effects of Sal B and TAK-242 on cell viability and apoptosis. (a) The cotreatment
  with Sal B and TAK-242 did not further enhance cell viability. n = 5. Data are the
  mean ± SD. ∗∗P < 0.01 vs. control group; ##P < 0.01 vs. iopromide group. (b) The
  effect of cotreatment with Sal B and TAK-242 obtained using flow cytometry. n = 3.
  Data are the mean ± SD. ∗∗P < 0.01 vs. control group; ##P < 0.01 vs. iopromide group.'
article_title: Salvianolic Acid B Attenuates Iopromide-Induced Renal Tubular Epithelial
  Cell Injury by Inhibiting the TLR4/NF-κB/NLRP3 Signaling Pathway.
citation: Ming Xin Pei, et al. Evid Based Complement Alternat Med. 2022;2022:8400496.
year: '2022'

doi: 10.1155/2022/8400496
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
